Shareholder Rights Law Firm Johnson Fistel Launches Investigations

SAN DIEGO, July 2, 2019

Company Name	Stock Ticker	IPO Date	IPO Price	Closing Price July 2, 2019	Join the Action ARIVA.DE Börsen-Geflüster Kurse ENDOSTIM INC COM -   0,00% Kezar Life Sciences 0,65 € +2,36% Osmotica Pharmaceuticals -   $ 0,00% Pharol ADR -   0,00%
Pintec Technology Holding Limited	(NASDAQ: PT)	10/25/2018	$11.88	$3.58	Click Here
Osmotica Pharmaceuticals plc	(NASDAQ: OSMT)	10/18/2018	$7.00	$3.75	Click Here
Kezar Life Sciences, Inc.	(NASDAQ: KZR)	6/21/2018	$15.00	$7.01	Click Here
Neuronetics, Inc.	(NASDAQ: STIM)	6/28/2018	$17.00	$12.51	Click Here
U.S. Xpress Enterprises, Inc.	(NYSE: USX)	6/14/2018	$16.00	$5.30	Click Here

Specifically, Johnson Fistel's investigation seeks to determine whether the filings by the companies listed above with the U.S. Securities and Exchange Commission in connection with their recent IPOs, respectively, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the businesses, operations, and prospects of the companies listed above.

If you have information that could assist in this investigation, including past employees and others, or if you are a shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

View original content:http://www.prnewswire.com/news-releases/shareholder-rights-law-firm-johnson-fistel-launches-investigations-300879674.html

SOURCE Johnson Fistel, LLP